These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9854148)

  • 1. Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis (review).
    Andres V
    Int J Mol Med; 1998 Jul; 2(1):81-9. PubMed ID: 9854148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases.
    Rivard A; Andrés V
    Histol Histopathol; 2000 Apr; 15(2):557-71. PubMed ID: 10809377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease.
    Sanz-González SM; Poch E; Pérez-Roger I; Díez-Juan A; Ivorra C; Andrés V
    Front Biosci; 2000 Jul; 5():D619-28. PubMed ID: 10877996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.
    Sata M; Saiura A; Kunisato A; Tojo A; Okada S; Tokuhisa T; Hirai H; Makuuchi M; Hirata Y; Nagai R
    Nat Med; 2002 Apr; 8(4):403-9. PubMed ID: 11927948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
    J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
    Nikol S; Höfling B
    Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G; Aycock JK; Frati G; Napoli C
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.
    Ip JH; Fuster V; Badimon L; Badimon J; Taubman MB; Chesebro JH
    J Am Coll Cardiol; 1990 Jun; 15(7):1667-87. PubMed ID: 2188991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense therapy for angioplasty restenosis. Some critical considerations.
    Bennett MR; Schwartz SM
    Circulation; 1995 Oct; 92(7):1981-93. PubMed ID: 7671381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Break the cycle: the role of cell-cycle modulation in the prevention of vasculoproliferative diseases.
    Ferguson JE; Patterson C
    Cell Cycle; 2003; 2(3):211-9. PubMed ID: 12734427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells.
    Lövdahl C; Thyberg J; Cercek B; Blomgren K; Dimayuga P; Kallin B; Hultgårdh-Nilsson A
    Histol Histopathol; 1999 Oct; 14(4):1101-12. PubMed ID: 10506926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heterogeneity of smooth muscle cells and intima thickening of various genesis and in organized thrombi].
    Shekhonin BV; Tararak EM; Zotikov AE
    Biull Eksp Biol Med; 1996 Aug; 122(8):222-7. PubMed ID: 9081484
    [No Abstract]   [Full Text] [Related]  

  • 14. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development.
    Hao H; Gabbiani G; Bochaton-Piallat ML
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1510-20. PubMed ID: 12907463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
    Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic engineering of vein grafts resistant to atherosclerosis.
    Mann MJ; Gibbons GH; Kernoff RS; Diet FP; Tsao PS; Cooke JP; Kaneda Y; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4502-6. PubMed ID: 7753833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity.
    McCaffrey TA; Nicholson AC; Szabo PE; Weksler ME; Weksler BB
    J Exp Med; 1988 Jan; 167(1):163-74. PubMed ID: 3335829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis.
    McNamara CA; Sarembock IJ; Bachhuber BG; Stouffer GA; Ragosta M; Barry W; Gimple LW; Powers ER; Owens GK
    Semin Thromb Hemost; 1996; 22(2):139-44. PubMed ID: 8807710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Saireitoh on rabbit smooth muscle cell proliferation and experimental atherosclerosis.
    Watanabe H; Takahashi Y; Fujioka T; Kanmatsuse K
    J Atheroscler Thromb; 2000; 6(2):33-41. PubMed ID: 10872612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
    Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
    J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.